Precision Medicine Podcast · Trapelo

Liquid Biopsy Part 1: Breaking Speed and Access Barriers in Precision Oncology

·35 min·5 clips
He is a tireless advocate for closing the gaps that prevent too many patients, especially in the com...
Precision Medicine Podcast begins a two-part conversation on liquid biopsy and treats it as a practical way to bring precision medicine to more patients. The episode starts with a basic clinical problem: some cancers move so fast that time becomes a real factor. Diffuse large B-cell lymphoma and aggressively spreading small cell lung cancer are used as examples of diseases where a reporting delay can matter a lot. The show describes liquid biopsy as a blood-based test that can be drawn according to specification, shipped the same day, and often returned within five to seven days. That speed is not treated as a nice extra. It is part of the argument for making precision medicine easier to use in ordinary care. The conversation also links liquid biopsy with MRD testing and asks what changes if blood-based monitoring can match, or even outperform, radiological imaging in some tumor types. If that happens, patients may need less radiation and fewer trips back and forth. Mobile phlebotomy comes up as one way to make that real. A sample could be drawn at home and sent off for testing. The discussion keeps circling back to patient-centered cancer care rather than technology for its own sake. One example involves a 44-year-old man with stage four melanoma. His disease had spread to the bones, which makes radiologic response especially hard to judge. After MRD testing was approved and covered by payers, the team began tracking him with blood tests. He had been MRD negative for over a year. Based on that result, treatment intervals were stretched gradually. The hope was to stop treatment altogether in about six months. The case shows how stable imaging does not always tell the full story. It also shows how MRD may support more confident treatment decisions when imaging is unclear. Across the episode, the focus stays on access, timing, and the practical impact of better testing.

As heard by us

A clear look at how faster blood testing, mobile phlebotomy, and MRD monitoring could make cancer care more practical.

Liquid biopsy is framed as a blood test that can deliver results in five to seven days, a speed that matters when fast moving cancers leave little room to wait.

Read the full review in PlayNext →

Why you'd press play

Hear how a blood test can turn some cancer results from 30 days into about a week.

Read the full recommendation in PlayNext →
Listen to the show on